| ||
| Acton Pharma ready to launch asthma treatment Mass High Tech Acton Pharmaceuticals Inc. of Marlborough his received approval from the U.S. Food and Drug Administration of its supplemental New Drug Appliciation (sNDA) for an inhaled steroid to treat asthma. The FDA approved the application for AEROSPAN, an oral ... See all stories on this topic » | ||
| SkyePharma launches asthma treatment in Germany Stock Market Wire flutiform® was approved for the treatment of asthma maintenance therapy in Germany by its regulatory authority, Bundesinstitut für Arzneimittel und Medizinprodukte (BfARM), in July. Following the launch offlutiform® in Germany, a milestone of €4.0m is ... See all stories on this topic » | ||
| Consult doctor on pros and cons of asthma medicine Charlotte Observer I recently read that budesonide (a medication he takes for his asthma) could affect his height as an adult. Should he stop taking this medication? Budesonide is an inhaled glucocorticoid (steroid) medication used to treat asthma. A recent study in the ... See all stories on this topic » |
| ||
| New asthma treatment at OU Med | KFOR.com – Oklahoma City ... By KFOR-TV New asthma treatment at OU Med: Suffer from asthma? Get more information on this new treatment here.... KFOR.com – Oklahoma City News... |
| ||
| New asthma treatment a relief for Lincoln woman : The (402)/411 2012-09-23T06:00:00Z 2012-09-22T19:44:12Z New asthma treatment a relief for Lincoln womanBy MARK ANDERSEN / Lincoln Journal Star JournalStar.com ... journalstar.com/.../article_f19de395-7176-518c-80d0-057193... | ||
| prednisone dosage asthma treatment | prescription drugs, generic ... prednisone dosage asthma treatment -> Illustrated catalog of health :: prednisone dosage asthma treatment... SUPER DISCOUNT - prednisone dosage asthma ... drugalternativeprogram.org/?oseiuj=prednisone-dosage... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment